ArticleOncotarget2017

Sensitization of glycoengineered interferon-β1a-resistant cancer cells by cFLIP inhibition for enhanced anti-cancer therapy.

Tae-Eun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.